Burton E. Sobel
Burton E. Sobel holds an M.D. degree. He is the Director of the Cardiovascular Research Institute at the University of Vermont and University Distinguished Professor of medicine and a Professor of biochemistry at the University of Vermont and Fletcher Allen Health Care. He is a graduate of Cornell University, Ithaca, NY, USA, and Harvard Medical School, Cambridge, Mass, USA, magna cum laude; his clinical training was at the Peter Bent Brigham Hospital and the NIH; and he has held leadership positions at UCSD, Washington University and Barnes Hospital (Director of Cardiology), and the University of Vermont (Chair, Department of Medicine). His research interests are in diabetes and heart disease, quantification of infarct size, favorable modification of fibrinolysis, molecular mechanisms underlying evolution of vulnerable atherosclerotic plaques, and heart failure in diabetes. He has served as the President of the SEBM and has been repeatedly honored with an RCDA by the NIH, a Distinguished Scientist Award from the ACC, a Distinguished Achievement Award from the AHA and the ACC, an International Recognition Award from the Heart Research Foundation, and a Mastership from the ACP. He has published more than 970 manuscripts and served major cardiovascular and medical scientific journals including Circulation, Editor; Journal of Clinical Investigation, Associate Editor; American Journal of Physiology, Associate Editor; Coronary Artery Disease, Editor; Current Opinion in Cardiology, Editor; Fibrinolysis, Associate Editor; and Circulation Research, Annals of Internal Medicine, American Journal of Cardiology, American Journal of Medicine, and Diabetes Care, Editorial Board Member.
Biography Updated on 8 February 2012